MIND Center and Mayo Clinic Expand Research on Individual Dementia Risk

UMMC's MIND Center and Mayo Clinic are studying individualized dementia-risk estimates. See how the projects differ and why validation matters.

MIND Center and Mayo Clinic Expand Research on Individual Dementia Risk
Share
White Reddit alien mascot face icon on transparent background.White paper airplane icon on transparent background.White stylized X logo on black background, representing the brand X/Twitter.
Oct 27, 2026
Cognitive Health & Protection

On October 19, 2026, the University of Mississippi Medical Center (UMMC) MIND Center and Mayo Clinic announced two separate research efforts: an international dementia-risk prediction initiative and a separate NIH U19-funded aging research program.

What are the two research efforts studying?

The UMMC announcement describes related projects with different designs. One seeks more individualized estimates of future cognitive impairment and dementia. The other brings together aging studies to examine why cognitive health changes and why risk varies between people.

An international prediction initiative

According to UMMC, the international initiative will draw on long-term studies at the MIND Center and Mayo Clinic in Rochester. Research sites in Spain and Australia are also involved. Researchers plan to follow thousands of people over time, but the announcement gives no specific participant total for this initiative.

The planned approach combines health data and biomarkers with blood tests and brain images. MIND Center researcher Gwen Windham described the ambition as developing “personalized, absolute risk predictions” rather than relying on traditional population-level estimates.

That is a change in the question being asked. A population estimate describes risk across a group. The proposed approach aims to use more of a person's own information when estimating their future likelihood of cognitive impairment or dementia.

Windham also pointed to the value of combining cohorts and research expertise. In the announcement, she said that broader populations and datasets may help make future estimates useful for more diverse patient groups. That is one reason the international collaboration matters beyond the size of any single study.

A separate aging research program

The separate aging effort is supported by a $23 million NIH U19 award. It brings together the Mayo Clinic Study of Aging and the UMMC MIND Center-Mayo Clinic Study of Aging.

UMMC reports that this program involves about 5,000 participants across both sites. About 2,000 are expected to enroll during this phase and be followed in Mississippi. Those figures belong to the U19 program rather than the international prediction initiative.

For the U19 work, the announcement describes several kinds of information:

  • Blood tests and brain imaging to study biological changes.
  • Memory exercises that assess cognitive performance.
  • Health and lifestyle questionnaires plus physical assessments.
  • Monitors that track movement and rest for some participants.

The program will study Alzheimer's disease and cerebrovascular disease, which can contribute to cognitive decline. MIND Center director Thomas H. Mosley described its goal as understanding who is at risk and why risk differs. He also described the aim of identifying people early enough to intervene.

UMMC says the projects include people living in the community rather than relying only on recruitment from specialty clinics. This fits the stated goal of making findings relevant to broader populations.

The partners bring different areas of experience. Mayo Clinic contributes clinical research and expertise in imaging and biomarkers. The MIND Center contributes work on aging and cardiovascular risks, including experience with the Atherosclerosis Risk in Communities study.

What changes for adults over 60 and their clinicians?

For researchers, the immediate task is to connect several kinds of information: biological measures and brain images alongside memory performance and health history. The announcement puts these pieces within shared research efforts. For readers following cognitive-health news, that offers a more complete picture of what individualized risk research involves.

For adults interested in taking part, research participation is the most concrete issue raised by the announcement. UMMC describes memory exercises and other assessments that participants complete. Some also contribute information about movement and rest through monitors.

People seeking study information from the MIND Center or Mayo Clinic can ask:

  • What are the eligibility requirements?
  • Which assessments would participation involve?
  • How will participant information be handled?

The announcement outlines study procedures but does not supply complete eligibility criteria or a general enrollment contact. It also gives no calendar dates for the overall Mississippi enrollment period. These are details to check with the study team rather than infer from the participant targets.

For patients and clinicians, the practical value today is a clearer understanding of the research questions. The projects ask how different sources of information might work together to explain individual risk. The focus is the relationship between biological findings and changes in thinking over time.

Does this mean a personal dementia-risk test is ready?

No. UMMC's announcement describes research in progress, not a consumer-ready test. It reports no accuracy statistics for the planned tools and does not establish that they are ready to guide individual care. Researchers must first show that the tools work reliably across populations and in everyday care.

The blood tests in these projects are research components within a wider set of assessments. Nothing in the announcement establishes that a blood test alone can predict an individual's future dementia risk.

Mayo Clinic Press offers related context through its discussion of a 2025 study. That study used brain amyloid measurements alongside factors including age and sex. Genetic risk was also among the inputs used to estimate future risk of mild cognitive impairment and dementia. The article explicitly distinguishes estimating risk from diagnosing Alzheimer's disease.

Medscape's reporting on blood-based Alzheimer's tests draws another boundary. It says these tests should be interpreted within an appropriate clinical evaluation rather than treated as stand-alone screening answers for people without symptoms. A test that helps identify Alzheimer's-related pathology during a clinical workup is not automatically a validated forecast of future dementia.

If changes in memory or thinking are concerning, a qualified clinician can discuss assessment and interpretation in the context of the person's situation. The relevant question is what a test result means within that evaluation, not what a result appears to predict in isolation.

Related FitBrainLab articles explain where blood testing fits into memory care and why testing without symptoms raises different questions. These are separate clinical discussions from the development of future risk models.

A useful way to read the next prediction headline is to ask what was actually demonstrated. Was a tool tested in people, or was a project announced? Does the report describe prediction, diagnosis or a research goal? Keeping those categories separate makes an ambitious study easier to judge without turning its aims into personal expectations.

Why does this research matter for long-term brain health?

The value of this collaboration lies in bringing different views of cognitive aging into the same research effort. Blood measures and brain imaging are being studied alongside memory performance and information about health and daily life. Community participation adds another part of that broader perspective.

For long-term cognitive health, the meaningful direction is toward understanding why risk differs between individuals. Better individualized estimates could make future discussions more informative. The MIND Center-Mayo work matters because it tackles that question through combined expertise and long-term study.

How FitBrainLab helps

Dementia-risk questions sit with older adults and their clinical teams; FitBrainLab takes on the editorial work of making the underlying science understandable. For adults 60+, its reporting distinguishes established knowledge from developing claims so an ambitious prediction project can be judged on evidence rather than expectations about future memory loss.

Explore Resources

Sources

  1. National awards boost MIND Center-Mayo Clinic efforts to ...
  2. Is Social Media Overselling Alzheimer's Blood Testing?
  3. Detecting Alzheimer's before symptoms develop

Follow FitBrainLab for research-led insights on memory, focus, brain aging, nutrition and mental fitness after 60. Stay connected for new articles, practical guidance and ideas for a sharper, more engaged life.

White stylized X logo on black background, representing the brand X/Twitter.

Continue reading

November 21, 2026
Cognitive Health & Protection

Healthcare Providers Urged to Screen for Ongoing Loneliness Beyond Household Arrangements

read article
November 20, 2026
Cognitive Health & Protection

Examining How Fourteen Modifiable Risk Factors Across a Lifetime Shape Dementia Prevention

read article
November 19, 2026
Cognitive Health & Protection

Focusing on Daily Connection Rather Than Cognitive Decline When Treating Hearing Loss

read article
lifelong curiosity

Your sharpest years can still be ahead

Build habits that support memory, focus and a curious, connected life.

Read the Blog